DVYSR — Devyser Diagnostics AB Share Price
0.000.00%
Last trade - 00:00- SEK1.62bn
- SEK1.53bn
- SEK216.90m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 70.75 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.63 | ||
| Price to Tang. Book | 6.55 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 7.46 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -14.53% | ||
| Return on Equity | -16.76% | ||
| Operating Margin | -26.88% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 65.69 | 93.48 | 126.61 | 169.3 | 216.9 | 292.25 | 394.25 | 27.53% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +554.4 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Devyser Diagnostics AB is a Sweden-based company engaged in development, manufacture ad sale of kits for genetic testing in routing diagnostic to laboratories. The products are used for complex deoxyribonucleic acid (DNA) testing in the areas of hereditary diseases, oncology, and post-transplantation monitoring in order to diagnose genetic diseases and target cancer treatment. The company has since its inception developed and launched almost 30 products for routine diagnostic use, including Devyser Thrombophilia assay as well as Devyser Resolution XY for analysis of chromosomes X and Y. Devyser Diagnostics’ products are sold directly to the end customer or through hired distributors. The Company provides its products in more than 45 countries.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- October 12th, 2004
- Public Since
- December 10th, 2021
- No. of Employees
- 132
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 16,554,114
- Address
- Instrumentvagen 19, HAGERSTEN, 126 53
- Web
- https://www.devyser.com/
- Phone
- +46 856215850
- Auditors
- PricewaterhouseCoopers AB
Upcoming Events for DVYSR
Q1 2025 Devyser Diagnostics AB Earnings Call
Devyser Diagnostics AB Annual Shareholders Meeting
Devyser Diagnostics AB Annual Shareholders Meeting
Q2 2025 Devyser Diagnostics AB Earnings Release
Similar to DVYSR
2cureX AB
OMX Nordic Exchange Stockholm
Acousort AB
OMX Nordic Exchange Stockholm
Active Biotech AB publ
OMX Nordic Exchange Stockholm
Alligator Bioscience AB
OMX Nordic Exchange Stockholm
AlzeCure Pharma AB
OMX Nordic Exchange Stockholm
FAQ
What is the Devyser Diagnostics AB share price?
As of Today at 20:13 UTC, shares in Devyser Diagnostics AB are trading at SEK97.70. This share price information is delayed by 15 minutes.
How has the Devyser Diagnostics AB share price performed this year?
Shares in Devyser Diagnostics AB last closed at SEK97.70 and the price had moved by -5.15% over the past 365 days. In terms of relative price strength the Devyser Diagnostics AB share price has underperformed the FTSE Global All Cap Index by -7.52% over the past year.
What are the analyst and broker recommendations for Devyser Diagnostics AB?
The overall consensus recommendation for Devyser Diagnostics AB is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Devyser Diagnostics AB dividend yield?
Devyser Diagnostics AB does not currently pay a dividend.
Does Devyser Diagnostics AB pay a dividend?
Devyser Diagnostics AB does not currently pay a dividend.
When does Devyser Diagnostics AB next pay dividends?
Devyser Diagnostics AB does not currently pay a dividend.
How do I buy Devyser Diagnostics AB shares?
To buy shares in Devyser Diagnostics AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Devyser Diagnostics AB?
As of the previous close price of SEK97.70, shares in Devyser Diagnostics AB had a market capitalisation of SEK1.62bn.
Where are Devyser Diagnostics AB shares listed?
Here are the trading details for Devyser Diagnostics AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: DVYSR
What kind of share is Devyser Diagnostics AB?
Based on an overall assessment of its quality, value and momentum Devyser Diagnostics AB is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Devyser Diagnostics AB share price forecast for 2025?
The analyst consensus target price for shares in Devyser Diagnostics AB is SEK164.00. That is 67.86% above the last closing price of SEK97.70.
Analysts covering Devyser Diagnostics AB currently have a consensus Earnings Per Share (EPS) forecast of SEK0.50 for the next financial year.
Find out moreWhat is the trend in the Devyser Diagnostics AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Devyser Diagnostics AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -23.47%.
As of the last closing price of SEK97.70, shares in Devyser Diagnostics AB were trading -17.83% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Devyser Diagnostics AB PE Ratio?
The Devyser Diagnostics AB PE ratio based on its reported earnings over the past 12 months is 70.75. The shares last closed at SEK97.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Devyser Diagnostics AB?
We do not have data on Devyser Diagnostics AB's directors